At the American Association for Clinical Chemistry (AACC) Annual Meeting, Waters Corp unveiled new technology solutions for increasing clinical laboratory efficiencies including the first CE-marked LC/MS/MS integrated solution for the quantification of everolimus (Certican®).

The company also exhibited its MassTrak™ Online Solid Phase Extraction Analyzer, which provides automated sample clean-up, concentration, and extraction complemented by Waters® ACQUITY® TQD tandem quadrupole mass spectrometer for high-sensitivity quantitative analysis; and its MassTrak Immunosuppressants XE Kit, CE marked in accordance with the IVD Directive 98/79/EC for the quantification of tacrolimus (FK506;Prograf®) in liver and kidney transplant patients and everolimus (Certican).

Source: Waters Corp